Newsbenzinga
Cellectar Biosciences Q2 2026 Earnings Call Transcript
· Published
Article summary
On Thursday, Cellectar Biosciences (NASDAQ:CLRB) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For
An excerpt from the original article.
Comments —
Loading comments…